The first reported use of the SMASh tag system in a genetically engineered mouse model involved fusion of SMASh, together with an mCherry reporter, to the C-terminus of the PD-1 (PDCD1) protein, a cell surface receptor involved in immune checkpoint control and an important target for cancer immunotherapy (Naruse et al., 2022). Here, PDCD1 is linked to cancer.